Studies associated with ontology term
MA:0003000   'anatomical structure'    
Navigate ontologies  


Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Ackerman1 study archive
with methacholine 		Lung, respiratory function, baseline and methacholine-challenged (several doses). QTL population f 7-8wks 2005
Ackert1 DXA Body mass, fat mass, lean mass, bone mineral density and content, body area, bone area. Aging study, 6mo, 12mo, 20mo. inbred   (32) both 26, 52, 87 wks 2008
Albers1 lipid profile
with high-fat diet 		Cholesterol, HDL, non-HDL, triglycerides, phospholipids. 4h fast, plasma. Baseline vs. high-fat diet (6wks). inbred   (15) both 6-14wks 1999
Albers1 protein activity assessment
with high-fat diet 		Phospholipid transfer protein activity. 4h fast. inbred   (15) both 6-14wks 1999
Ankra-Badu1 study archive Body, organ, fat pad weights, weight gain, litter size. QTL population both 2-10wks 2009
Attie2 metabolic panel
with high-fat high-sucrose diet 		Glucose, HOMA-IR, HOMA-B. DO population both 4-26wks 2018
Attie2 hormone quantification
with high-fat high-sucrose diet 		Plasma insulin, adiponectin, leptin. Ex vivo insulin secretion. DO population both 4-26wks 2018
Attie2 lipid profile
with high-fat high-sucrose diet 		Triglyceride. DO population both 4-26wks 2018
Attie2 glucose tolerance
with high-fat high-sucrose diet 		Area under curve. DO population both 4-26wks 2018
Attie2 microscopy
with high-fat high-sucrose diet 		Number of islets harvested. DO population both 4-26wks 2018
Attie2 DXA
with high-fat high-sucrose diet 		Bone mineral density. Isolated tibia. DO population both 4-26wks 2018
Attie2 organ weights
with high-fat high-sucrose diet 		Heart, liver, gonadal fat pads. DO population both 4-26wks 2018
Attie2 biomarker quantification
with high-fat high-sucrose diet 		Bile acids in feces. DO population both 4-26wks 2018
Auwerx1 NMR
with high-fat diet 		Body composition. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 monitoring system
with high-fat diet 		Oxygen consumption and respiratory exchange ratio (RER); activity. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 glucose tolerance
with high-fat diet 		Glucose post oral gavage: 0, 15, 30, 45, 60, 90, 120, 150, 180 min plus area under curve. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 hormone quantification
with high-fat diet 		Glucose post oral gavage: 0, 15, 30 min plus area under curve. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 tail cuff
with high-fat diet 		Blood pressure and heart rate. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 metabolic panel
with high-fat diet 		Enzymes, bile acid, proteins, creatinine, glucose, iron, lactate. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 lipid profile
with high-fat diet 		Cholesterol, HDL, LDL, free fatty acids, triglyceride. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 cell signaling molecule detection
with high-fat diet 		INF-gamma, interleukins, monocyte chemoattractant, macrophage inflammatory protein, T cell RANTES, TNF-alpha. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 complete blood count
with high-fat diet 		RBC, hematocrit. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 organ weights
with high-fat diet 		Skeletal muscle, soleus muscle, heart, kidney, liver, various fat pads. BXD w/par   (57) m 8-29 wks 2016
Auwerx2 monitoring system
with high-fat diet 		Oxygen consumption, carbon dioxide production, respiratory exchange rate (RER); activity. inbred w/CC8 both 8-21 wks 2021
Auwerx2 glucose tolerance
with high-fat diet 		Plasma glucose levels: 0, 15, 30, 45, 60, 90, 120, 150, and 180 min, post oral gavage following overnight fast. inbred w/CC8 both 8-21 wks 2021
Auwerx2 hormone quantification
with high-fat diet 		Insulin levels following glucose post oral gavage: 0, 15, 30 min. inbred w/CC8 both 8-21 wks 2021
Auwerx2 organ weights
with high-fat diet 		Cecum, muscles, heart, heart-atria, kidney, liver, spleen, fat pads. inbred w/CC8 both 8-21 wks 2021
Auwerx2 organ dimensions
with high-fat diet 		Intestine length. inbred w/CC8 both 8-21 wks 2021
Auwerx2 metabolic panel
with high-fat diet 		Enzymes, creatinine, iron, lactate, urea. inbred w/CC8 both 8-21 wks 2021
Auwerx2 lipid profile
with high-fat diet 		Cholesterol, HDL, LDL, triglycerides, free fatty acids. inbred w/CC8 both 8-21 wks 2021
Bachmanov1 bottle choice test Sodium chloride solution taste threshold. Fluid intake. inbred   (13) m 7-8wks 2011
Bautz1 study archive Plasma lipids. Cholesterol, triglycerides. QTL population both 12-14wks 2013
Beamer1 study archive Bone volume. QTL population f 20wks 1999
Beamer2 study archive Bone morphology and strength, insulin-like growth factor 1. QTL population f 16wks 2001
Bennett2 colony observation Appearance, coat color. ILSXISS   (102) f various 2005
Bennett3 alcohol quantification
with ethanol 		Blood alcohol concentrations after ethanol injection over time, acute functional ethanol tolerance. ILSXISS w/par   (74) both 8-14wks 2007
Bennett4 MRI Body composition (lean, fat, water). both 8-20wks 2021
Bennett4 metabolic panel Plasma enzymes, creatinine, glucose, urea, metabolic health score. both 8-20wks 2021
Bennett4 lipid profile Cholesterol, non-esterified fatty acids, triglyceride. both 8-20wks 2021
Bennett4 biomarker quantification TMAO, choline, phosphocholine, glycerophosphocholine, betaine, carnitine. both 8-20wks 2021
Bennett4 hormone quantification Insulin, glucose:insulin ratio. both 8-20wks 2021
Bennett4 monitoring system O2 consumption, CO2 production, RER, heat expenditure, activity. both 8-20wks 2021
Benoist1 immune cell quantification Regulatory T cells (Treg), thymus, spleen. inbred   (33) m 5-6wks 2007
Berndt1 ventilator
with methacholine 		Airway resistance. Baseline vs. methacholine-challenged (several doses). inbred   (37) both 9-12wks 2010
Berndt2 plethysmography
with methacholine 		Lung, respiratory function. Baseline vs. methacholine-challenged (several doses). inbred   (29) both 9-12wks 2010
Berndt2 ventilator
with methacholine 		Lung, respiratory function. Anesthetized forced oscillation. Baseline vs. methacholine-challenged (several doses). inbred   (29) both 9-12wks 2010
Berndt3 metabolite quantification Vitamin D concentration (serum). inbred   (18) m 11wks 2011
Berndt4 histopathology Lung adenoma frequency and severity at 20mo. Tumor incidence, cancer, aging. inbred   (28) both 87wks 2011
Bodnar1 intake monitoring
with sucrose 		Food, caloric, water intake. Baseline and with sucrose (several concentrations). 24h test. inbred   (12) m 13-17wks 2006
Bopp1 health assessment
with Plasmodium berghei 		Susceptibility, Plasmodium berghei (malaria). Parasitemia in blood and distribution in brain, spleen, lungs, liver. inbred   (31) both 8-12wks 2010
Bouma1 study archive Fetal gonads microscopy study. QTL population m embryo 2005
Brich1 study archive Protein tau hyperphosphorylation. QTL population f 3wks 2003
Brinkmeyer1 RNA expression profiling
with Theiler's murine encephalomyelitis virus 		TMEV transcript abundance. CC   (5) both 4wks 2017
Brinkmeyer1 gait analysis
with Theiler's murine encephalomyelitis virus 		DigiGait analysis and footprint analysis, TMEV infection. CC   (5) both 4wks 2017
Brockmann1 study archive Body, organ weights, litter size, abdominal fat, lipids, insulin, leptin. QTL population both 3-6wks 2009
Broman1 study archive Gut length. QTL population both 2006
Brugnara1 complete blood count Hematology. inbred   (10) both 8wks 2013
Brugnara1 ion transport assessment Hematology red cell ion content, ion transport. inbred   (10) both 8wks 2013
Burke1 study archive Femur and vertebra morphology and strength. Monthly body weight 3 - 13 months. QTL population f 14-56wks 2012
CGDpheno1 metabolic panel Clinical blood chemistry (plasma). 4h fast. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 complete blood count Hematology. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 lipid profile Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno1 DXA Body mass, fat mass, lean mass, bone mineral density. inbred w/CC8   (72) both 10-13wks 2009
CGDpheno3 metabolic panel Glucose (plasma). 4h fast. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 lipid profile Cholesterol, HDL, triglycerides. 4h fast, plasma. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 complete blood count Hematology. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 tail cuff Heart rate and blood pressure. Conscious mice. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 ECG Wave amplitudes and intervals. Conscious. CC diallel w/par   (62) both 8-16wks 2012
CGDpheno3 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC diallel w/par   (62) both 8-16wks 2012
Chang1 organ dimensions Eye diameter. inbred   (17) both 10-13wks 2008
Chang1 electroretinography Photoreceptor measures: rod Awave, Bwave, cone Bwave. inbred   (17) both 10-13wks 2008
Chang2 slit lamp Eye morphology. Frequency rates of disorders. B6.PWD consomic w/par   (28) both 44-61wks 2012
Chang2 ophthalmoscopy Retinal spots, hypopigmentation. B6.PWD consomic w/par   (28) both 44-61wks 2012
Chen1 immune cell quantification Natural killer T cells in peripheral blood, spleen, thymus. inbred   (38) both 8-10wks 2011
Chesler2 metabolic panel Clinical blood chemistry. 16h fast. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 complete blood count Hematology. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 colony observation Reproduction, fecundity. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 body size and weight Body weight, body length, tail length. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 fat pad weights Gonadal fat pad weight. CC diallel w/par   (62) both 7-15wks 2011
Chesler2 organ weights Heart, kidney weights. CC diallel w/par   (62) both 7-15wks 2011
Chesler3 metabolic panel Clinical blood chemistry. 16h fast. CC pre w/par   (367) both 7-15wks 2011
Chesler3 complete blood count Hematology. CC pre w/par   (367) both 7-15wks 2011
Chesler3 colony observation Reproduction, fecundity. CC pre w/par   (367) both 7-15wks 2011
Chesler3 body size and weight Body weight, tail length. CC pre w/par   (367) both 7-15wks 2011
Chesler3 fat pad weights Gonadal fat pad weights. CC pre w/par   (367) both 7-15wks 2011
Chesler3 bone dimensions Femur. CC pre w/par   (367) both 7-15wks 2011
Chesler3 organ weights Heart, brain, kidney, spleen, gonadal fat pads, testicle weights. CC pre w/par   (367) both 7-15wks 2011
Chesler3 organ dimensions Kidney length and volume. CC pre w/par   (367) both 7-15wks 2011
Chesler6 study archive
with ethanol 		Sensitivity to ethanol. Baseline and ethanol. QTL population both 9-34wks 2012
Cheverud1 fat pad weights
with high-fat diet 		High-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 glucose tolerance
with high-fat diet 		High-fat diet (17wks) vs. control. 0 to 120 min after 10% glucose i.p. 4h fast. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 lipid profile
with high-fat diet 		Cholesterol, triglycerides, free fatty acids. High-fat diet (17wks) vs. control. 4h fast, serum. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 organ weights
with high-fat diet 		Heart, liver, kidney, spleen weights after high-fat diet (17wks) vs. control. LGXSM w/par   (19) both 12-16wks 2004
Cheverud1 hormone quantification
with high-fat diet 		Insulin, leptin. LGXSM w/par   (19) both 12-16wks 2004
Churchill1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. F1 8way   (63) both 7-8wks 2004
Churchill1 organ dimensions Ear length (pinal). F1 8way   (63) both 7-8wks 2004
Churchill1 muscle weights Quadriceps muscle. F1 8way   (63) both 7-8wks 2004
Clemens1 study archive
with ultraviolet light 		Immunosuppression of contact hypersensitivity after ultraviolet light exposure QTL population both 9-30wks 2000
Collins1 complete blood count Hematology. CC pre w/par   (139) m 10-14wks 2012
Cowell1 in vitro assay
with Staphylococcus aureus 		Bacterial load after infection with Staphylococcus aureus. Kidney and peritoneal fluid. In vitro assay. inbred   (13) f 8wks 2012
Cowell1 hormone quantification
with Staphylococcus aureus 		Interleukin 6 levels (serum) after infection with Staphylococcus aureus. Kidney and peritoneal fluid. inbred   (13) f 8wks 2012
Crabbe2 drug and metabolite quantification
with diazepam 		Diazepam (and metabolite) concentration in brain tissue immediately after diazepam injection and rotarod. inbred   (15) both 6-7wks 1998
Crabbe4 grip strength
with ethanol 		Baseline vs. 30 min after ethanol 2 g/kg i.p. inbred   (21) both 9-17wks 2003
Crabbe4 alcohol quantification
with ethanol 		Blood alcohol concentration after ethanol 2 g/kg i.p., several timepoints. inbred   (21) both 9-17wks 2003
Crowley1 drug and metabolite quantification
with haloperidol 		Haloperidol concentration (plasma). Baseline vs. during and after haloperidol 60d implant (several timepoints). inbred w/CC8   (27) m 9-28wks 2012
Crusio1 organ weights Brain weight. BXD w/par   (55) both 10-16wks 2018
Crusio1 histopathology Hippocampal histology. BXD w/par   (55) both 10-16wks 2018
CSNA01 operant conditioning chamber
with sucrose 		Rewards behavior and learning in a lever-based oral sucrose self-administering system. Daily 8 h sessions for 3 days. HMDP   (91) m 7-22wks 2018
Davidson1 study archive Exencephaly, neural tube defects in embryos. QTL population both embryo 2007
Deschepper1 organ weights Heart, kidney, thymus, adrena weights. inbred   (13) both 10wks 2004
Deschepper1 tail cuff Blood pressure. inbred   (13) both 10wks 2004
DiCurzio1 organ weights Adrenal weight. BXD w/par   (66) both 10wks 2010
DiCurzio1 histopathology Adrenal glands. BXD w/par   (66) both 10wks 2010
DiPetrillo1 urinalysis Microalbumin, creatinine, ratio. inbred w/CC7   (34) m 10wks 2012
DiPetrillo2 urinalysis Microalbumin, creatinine, ratio. CC pre w/par   (163) m 10wks 2012
DiPetrillo3 study archive Blood pressure (tail cuff), heart rate, heart weight. QTL population both 8wks 2004
Donahue1 DXA Body mass, fat mass, lean mass, bone mineral density and content, craniofacial dimensions. inbred w/CC7   (30) both 15-16wks 2002
Donahue1 metabolic panel Thyroxine (serum). inbred w/CC7   (30) both 15-16wks 2002
Donahue1 hormone quantification Osteocalcin, insulin-like growth factor 1. inbred w/CC7   (30) both 15-16wks 2002
Donahue10 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. B6.A consomic   (20) f 3-53wks 2011
Donahue11 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. B6.PWD consomic   (26) f 4-55wks 2011
Donahue12 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. AXB BXA   (28) f 3-50wks 2011
Donahue13 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. CXB   (13) f 3-50wks 2011
Donahue14 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. BXD   (42) f 3-60wks 2011
Donahue15 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. BXH   (11) f 3-55wks 2011
Donahue16 DXA Body mass, fat mass, bone mineral density. B6.A consomic w/par   (23) both 24-29wks 2012
Donahue17 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. BXD   (30) f 3-57wks 2011
Donahue18 monitoring system Gestation duration and weight gain during pregnancy. inbred   (15) f 6-8wks 2010
Donahue18 colony observation Reproduction, fecundity. Litter size, percent survival to day 3. inbred   (15) f 6-8wks 2010
Donahue18 body weight Pup body weight at day 3. inbred   (15) f 6-8wks 2010
Donahue19 monitoring system Gestation duration and weight gain during pregnancy. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue19 colony observation Reproduction, fecundity. Litter size, percent survival to day 3. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue19 body weight Pup body weight at day 3. B6.A consomic w/par   (22) f 6-8wks 2010
Donahue2 muscle weights Quadriceps muscle. inbred   (10) both 16wks 2004
Donahue2 DXA Femur bone mineral density and content, thigh cross sectional areas. inbred   (10) both 16wks 2004
Donahue2 bone dimensions Femur. inbred   (10) both 16wks 2004
Donahue2 computed tomography Bone morphology (femur). inbred   (10) both 16wks 2004
Donahue2 biomechanical test Bone strength. inbred   (10) both 16wks 2004
Donahue5 immune cell quantification White blood cell and immune cell differentials. B6.A consomic w/par   (22) both 7wks 2011
Donahue6 immune cell quantification White blood cell and immune cell differentials. B6.PWD consomic w/par   (28) both 7wks 2011
Donahue7 immunoglobulin quantification Immunoglobulin concentrations (plasma). B6.A consomic w/par   (22) both 9wks 2012
Donahue8 immunoglobulin quantification Immunoglobulin concentrations (plasma). B6.PWD consomic w/par   (28) both 9wks 2011
Donahue9 metabolic panel Clinical blood chemistry (serum). 4h fast. B6.PWD consomic w/par   (25) both 11wks 2011
Doorenbos1 study archive Urinalysis. Creatinine, microalbumin, body weight. QTL population m 8-10wks 2008
Dzur-Gejdosova1 study archive Sterility investigation. Sperm count, testes weight. QTL population m 9wks 2012
Eumorphia1 complete blood count Hematology. inbred   (8) both 12wks 2007
Eumorphia1 lipid profile Cholesterol, HDL, non-HDL, triglycerides, free fatty acids. Plasma. inbred   (8) both 12wks 2007
Eumorphia1 metabolic panel Clinical blood chemistry (plasma). Unknown fast. inbred   (8) both 12wks 2007
Eumorphia2 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred   (5) both 12, 24, 52 wks 2008
Eumorphia3 glucose tolerance 0 to 180 min after 20% glucose i.p. 16h fast. inbred   (4) both 12, 24, 52 wks 2008
Eumorphia6 echocardiography Cardiovascular function and morphology. inbred   (4) both 12wks 2008
Eumorphia6 organ weights Cardiac ventricle weight. inbred   (4) both 12wks 2008
Eumorphia6 tail cuff Heart rate. inbred   (4) both 12wks 2008
Eumorphia7 immunoglobulin quantification Immunoglobulin concentrations (serum). inbred   (6) both 9-12wks 2008
Everett1 bone dimensions Craniofacial bone dimensions. inbred   (14) both 9-12wks 2003
Farmer1 study archive Colitis susceptibility, severity. Colon histopathology, body and spleen weight. QTL population both 6wks 2001
Feng1 study archive Blood pressure (tail cuff), kidney weight, body weight. QTL population m 8wks 2009
Ferris1 histopathology
with influenza A (H1N1) virus 		Lungs and airway 4 days after infection with influenza A (H1N1) virus. CC pre w/par   (163) f 8-16wks 2012
Frankel1 electroconvulsion test
with lamotrigine 		Electroconvulsive thresholds. Lamotrigine. 2 test sites. inbred   (16) both 6-11wks 2000
French1 chromosome instability assessment
with benzene 		Percentages of erythrocytes and reticulocytes that are micronucleated before and after exposure. DO population m 5-8wks 2015
Gatti2 study archive Whole blood neutrophil count and white cell count. DO population both 10-12wks 2014
Gavras1 tail cuff
with sodium chloride 		Heart rate and blood pressure. Sodium chloride (1% solution for 2wks) vs. control. inbred   (11) both 9-12wks 2003
GMC02 grip strength Several trials. inbred w/CC8   (8) both 8-10wks 2020
GMC03 observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). inbred w/CC8   (8) both 8-10wks 2020
GMC05 acoustic startle test Acoustic startle response, prepulse inhibition. inbred w/CC8   (8) both 9-10wks 2020
GMC06 metabolic panel Glucose, glycerol. 16h fast. inbred   (5) both 10-11wks 2020
GMC06 lipid profile Cholesterol, HDL, non-HDL, triglycerides, fatty acids. 16h fast, plasma. inbred   (5) both 10-11wks 2020
GMC09 monitoring system Locomotor activity and energy metabolism. 21h test. inbred w/CC8   (8) both 12-13wks 2020
GMC10 NMR Body mass, fat and lean tissue mass. inbred w/CC8   (8) both 12-13, 18-19wks 2020
GMC11 glucose tolerance 0 to 120 min after 20% glucose i.p., 16h fast. inbred w/CC8   (6) both 13-14wks 2020
GMC12 echocardiography Cardiovascular function and morphology. inbred w/CC8   (8) both 14-15wks 2020
GMC13 ECG Heart rate and wave intervals. Conscious. inbred   (6) both 14-15wks 2020
GMC14 organ dimensions Axial length of eye. inbred w/CC8   (8) both 14-17wks 2020
GMC14 Scheimpflug imaging Eye lens density. inbred w/CC8   (8) both 14-17wks 2020
GMC14 computed tomography Retinal thickness and fundus vessels. inbred w/CC8   (8) both 14-17wks 2020
GMC14 virtual optomotor Threshold of spatial frequency. inbred w/CC8   (8) both 14-17wks 2020
GMC15 complete blood count Hematology. inbred w/CC8   (8) both 20-21wks 2020
GMC16 metabolic panel Clinical blood chemistry (plasma). No fast. inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC16 lipid profile Cholesterol, triglycerides. No fast, plasma. inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC17 ABR test Auditory brainstem response. inbred w/CC7   (7) both 17-18wks 2020
GMC18 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred w/CC8   (8) both 17-18wks 2020
GMC18 X-ray Lumbar vertebrae count. inbred w/CC8   (8) both 17-18wks 2020
GMC19 ventilator Lung, respiratory function. inbred w/CC8   (8) f 21-22wks 2020
GMC20 immunoglobulin quantification Immunoglobulins (plasma). inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC20 autoantibody quantification Anti-DNA autoantibodies, rheumatoid factor. inbred w/CC8   (8) both 16-17, 20-21wks 2020
GMC21 bone dimensions Tibia bone length. inbred w/CC8   (8) both 20-21wks 2020
GMC21 organ weights Heart, liver, spleen weights. inbred w/CC8   (8) both 20-21wks 2020
Gould1 drug and metabolite quantification
with lithium 		Lithium concentration in brain tissue and blood serum after lithium (several doses). inbred   (11) m 7-8wks 2011
Gould2 drug and metabolite quantification
with nicotine 		Amount of nicotine and cotinine in blood plasma after nicotine doses. High and lower doses. inbred   (8) m 8-12wks 2011
Graham1 immune cell quantification
with West Nile virus 		T cell populations in brain and spleen. CC RIX   (5) m 8-10wks 2015
Graham1 RNA expression profiling
with West Nile virus 		Viral load and expression of Ifnb1 and Ifit1 in brain, kidney and spleen. CC RIX   (5) m 8-10wks 2015
Graham2 in vitro assay
with SARS-CoV 		Lung viral load (log10). CC RIX   (117) f 8-10wks 2021
Graham3 immune cell quantification Baseline splenic T cell subsets. CC RIX   (104) m 8-10wks 2021
Graubert1 complete blood count
with ENU 		Hematology. inbred   (20) both 9wks; 12-64wks 2006
Graubert1 histopathology
with ENU 		Tumor growth frequency rates. ENU mutagen 100 mg/kg vs. control. inbred   (20) both 9wks; 12-64wks 2006
Gros1 in vitro assay
with Candida albicans 		Susceptibility to infection with Candida albicans. inbred   (36) f 8-12wks 2011
Gros1 genotype assessment
with Candida albicans 		C5 allele sufficiency or deficiency. inbred   (36) f 8-12wks 2011
Gros2 microscopy
with Plasmodium chabaudi 		Percent of Plasmodium chabaudi-infected erythrocytes in blood. inbred   (25) both 8-10wks 2012
Guay-Woodford1 study archive Kidney morphology, renal cystic disease severity. QTL population f 2wks 2000
Gupta1 organ weights Kidney weight of newborns. inbred   (8) both postnatal 2011
Gupta1 organ dimensions Kidney morphology of newborns. Planar surface area. inbred   (8) both postnatal 2011
Gupta1 renal function assay Vesico-ureteric reflux in newborns. Kidney function. inbred   (8) both postnatal 2011
Gupta2 organ weights Kidney weight of newborns. BXH   (10) both postnatal 2011
Gupta2 organ dimensions Kidney morphology of newborns. Planar surface area. BXH   (10) both postnatal 2011
Gupta2 renal function assay Vesico-ureteric reflux in newborns. Kidney function. BXH   (10) both postnatal 2011
Hackstein1 immune cell quantification Respiratory dendritic cell subsets and lymphocyte populations. inbred   (5) m 7-11wks 2012
Hadsell1 colony observation Maternal nurturing study. inbred   (31) f 14-18wks 2012
Hadsell2 mineral quantification concentrations of various minerals in milk inbred   (31) f 14-20wks 2018
Hageman1 study archive eQTL, urinary albumin excretion using microarray. QTL population m 8-10wks 2011
Hallgrimsson1 bone dimensions 3D, craniofacial landmark coordinates based on centroid. DO population both 8-60 wks 2020
Hampton1 ECG Heart rate and wave intervals. Conscious. inbred   (17) both 9-12wks 2001
Handel1 organ weights Male reproductive organ weights. Seminal vesicles, testicles. inbred   (14) m 8-10wks 2010
Handel1 sperm count Sperm count. Hemocytometer. inbred   (14) m 8-10wks 2010
Harrill1 organ weights
with isoniazid 		Body, liver, kidney weights. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 metabolic panel
with isoniazid 		Alanine transaminase. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 lipid profile
with isoniazid 		Cholesterol, triglycerides. Hepatic lipids. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill1 histopathology
with isoniazid 		Liver pathology scores. Isoniazid-treated vs. control. inbred   (34) f 8-10wks 2011
Harrill2 metabolic panel
with DB289 		Blood urea nitrogen, alanine transaminase, creatinine. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 urinalysis
with DB289 		Urine volume, creatinine. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 biomarker quantification
with DB289 		Kidney injury molecule 1 (KIM-1). DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 organ weights
with DB289 		Kidney and liver weights. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Harrill2 drug and metabolite quantification
with DB289 		Kidney metabolite (DB75) concentration. DB289-treated vs. control. inbred   (34) f 6-8wks 2012
Haston1 health assessment
with radiation 		Survival rate and health assessment after exposure to radiation. Number of days without respiratory distress (max 26 wks). inbred   (26) both 15-36wks 2012
Haston1 bronchoalveolar lavage assessment
with radiation 		Bronchoalveolar cell differential after exposure to radiation (18 Gy). inbred   (26) both 15-36wks 2012
Haston1 histopathology
with radiation 		Post exposure to radiation. inbred   (26) both 15-36wks 2012
Hawes1 slit lamp Eye morphology. Frequency rates of disorders. inbred w/CC7   (41) both 6-7wks 2008
Hawes1 ophthalmoscopy Retinal fundoscopic examination. inbred w/CC7   (41) both 6-7wks 2008
Hillebrands1 histopathology Kidney pathology at 20mo. inbred   (23) both 87wks 2014
HMDPpheno1 DXA Bone mineral density (whole body, femur, spine). HMDP   (96) m 16wks 2011
HMDPpheno11 histopathology
with high-fat high-cholesterol diet 		Aortic lesion size after 16 wks on high-fat diet. HMDP hAPOE and hCETP transgenic   (103) both 23-25 wks 2015
HMDPpheno2 NMR Percent fat. HMDP   (99) m 16wks 2010
HMDPpheno2 lipid profile Cholesterol, HDL, non-HDL, triglycerides, free fatty acids. 16h fast, plasma. HMDP   (99) m 16wks 2010
HMDPpheno3 tail cuff Heart rate and blood pressure. Conscious mice. HMDP   (58) m 9-10wks 2012
HMDPpheno5 complete blood count Hematology. HMDP   (83) m 16wks 2013
Hunter1 histopathology Metastatic progression of mammary tumor and genetic background. MMTV PyVT transgenic   (28) f various 1998
Iraqi1 computed tomography
with P.gingivalis and F.nucleatum 		Susceptibility to periodontitis. Mice infected with P. gingivalis and F. nucleatum vs. control. CC pre   (23) both 8wks 2013
Ishimori1 study archive
with high-fat diet 		Lipids, atherosclerosis lesions, parathyroid hormone after high-fat diet. QTL population f 20wks 2004
Jarvis1 study archive Fat pad weight. Epistatic interactions. QTL population both 13+wks 2011
Jax3 colony observation Reproductive performance. inbred   (33) f various 1991
Jax4 colony observation Appearance, coat color inbred   (61) both 2006
Jax5 colony observation Reproductive performance. inbred   (35) f various 2009
JaxCC1 ABR test Auditory brainstem response. CC   (18) both various 2018
JaxCC1 ECG Heart rate and wave intervals. Conscious. CC   (18) both various 2018
JaxCC1 grip strength 3 trials. CC   (18) both various 2018
JaxCC1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. CC   (18) both various 2018
JaxCC1 urinalysis Microalbumin, creatinine, ratio. CC   (18) both various 2018
JaxCC1 organ weights Heart weight. Raw and normalized to body weight. CC   (18) both various 2018
JaxCC1 hormone quantification Insulin (plasma). CC   (18) both various 2018
JaxCC1 complete blood count Hematology. CC   (18) both various 2018
JaxKOMP-EAP grip strength 3 trials. KOMP both 8-18wks 2021
JaxKOMP-EAP observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). KOMP both 8-18wks 2021
JaxKOMP-EAP ABR test Auditory brainstem response. KOMP both 8-18wks 2021
JaxKOMP-EAP acoustic startle test Acoustic startle response, prepulse inhibition. KOMP both 8-18wks 2021
JaxKOMP-EAP ECG Heart rate and wave intervals. Conscious. KOMP both 8-18wks 2021
JaxKOMP-EAP glucose tolerance 0 to 120 min after 20% glucose i.p., 16h fast. KOMP both 8-18wks 2021
JaxKOMP-EAP urinalysis Microalbumin, creatinine, ratio. KOMP both 8-18wks 2021
JaxKOMP-EAP lipid profile Cholesterol, HDL, triglycerides, fatty acids. 4h fast, plasma. KOMP both 8-18wks 2021
JaxKOMP-EAP X-ray Counts of vertebrae, ribs, digits, and other categorical parameters. KOMP both 8-18wks 2021
JaxKOMP-EAP DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. KOMP both 8-18wks 2021
JaxKOMP-EAP ophthalmoscopy Eye morphology. KOMP both 8-18wks 2021
JaxKOMP-EAP slit lamp Eye morphology. KOMP both 8-18wks 2021
JaxKOMP-EAP electroretinography Photoreceptor measures. KOMP both 8-18wks 2021
JaxKOMP-EAP metabolic panel Clinical blood chemistry (plasma). No fast. KOMP both 8-18wks 2021
JaxKOMP-EAP organ weights Heart weight. Raw and normalized to body weight. KOMP both 8-18wks 2021
JaxKOMP-EAP complete blood count Hematology parameters. KOMP both 8-18wks 2021
JaxKOMP-EAP hormone quantification Insulin (plasma). KOMP both 8-18wks 2021
JaxKOMP-LAP grip strength 3 trials. KOMP both 66-81wks 2021
JaxKOMP-LAP observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). KOMP both 66-81wks 2021
JaxKOMP-LAP ABR test Auditory brainstem response. KOMP both 66-81wks 2021
JaxKOMP-LAP acoustic startle test Acoustic startle response, prepulse inhibition. KOMP both 66-81wks 2021
JaxKOMP-LAP ECG Heart rate and wave intervals. Conscious. KOMP both 66-81wks 2021
JaxKOMP-LAP glucose tolerance 0 to 120 min after 20% glucose i.p., 16h fast. KOMP both 66-81wks 2021
JaxKOMP-LAP DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. KOMP both 66-81wks 2021
JaxKOMP-LAP ophthalmoscopy Eye morphology. KOMP both 66-81wks 2021
JaxKOMP-LAP slit lamp Eye morphology. KOMP both 66-81wks 2021
JaxKOMP-LAP metabolic panel Clinical blood chemistry (plasma). No fast. KOMP both 66-81wks 2021
JaxKOMP-LAP organ weights Heart weight. Raw and normalized to body weight. KOMP both 66-81wks 2021
JaxKOMP-LAP complete blood count Hematology parameters. KOMP both 66-81wks 2021
Jaxpheno1 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. inbred   (11) both 8, 16 wks 2006
Jaxpheno2 organ weights Brain, heart, kidney, liver, spleen weights. inbred   (11) both 8, 16 wks 2006
Jaxpheno3 metabolic panel Clinical blood chemistry (plasma). 4h fast. inbred   (11) both 8, 16 wks 2006
Jaxpheno3 lipid profile Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma. inbred   (11) both 8, 16 wks 2006
Jaxpheno4 complete blood count Hematology. inbred   (11) both 8, 16 wks 2006
Jaxpheno6 immune cell quantification White blood cell and immune cell differentials. inbred   (11) both 8, 16 wks 2006
Jaxpheno7 observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). inbred   (6) m 10wks 2010
Jaxpheno7 grip strength Peak tension. inbred   (6) m 10wks 2010
Jaxpheno8 ABR test Auditory brainstem response. inbred   (7) m 10-13wks 2010
Jaxpheno8 echocardiography Cardiovascular function and morphology. inbred   (7) m 10-13wks 2010
Jaxwest1 DXA Body mass, fat mass, lean mass, bone mineral density and content (whole body, femur, spine). inbred   (7) both 8-14wks 2003
Jaxwest1 ECG Heart rate and wave intervals. Conscious. inbred   (7) both 8-14wks 2003
Jaxwest1 tail cuff Heart rate and blood pressure. Conscious mice. inbred   (7) both 8-14wks 2003
Jaxwest1 grip strength Peak tension. inbred   (7) both 8-14wks 2003
Johnson1 ABR test Auditory brainstem response. inbred   (51) both 3-12wks and 15-72wks 2000
Johnson3 ABR test Auditory brainstem response. B6.A consomic w/par   (24) both 23-30wks 2012
Johnson4 ABR test Auditory brainstem response. B6.PWD consomic w/par   (28) both 49-63wks 2012
Jones1 vestibular stimulus test Vestibular function using evoked potentials. inbred   (16) both 49-63wks 2003
Justice2 complete blood count Hematology. inbred   (16) both 12-16wks 2002
Karst1 study archive Characterization of high-muscle-mass mice. QTL population both 3-10wks 2011
Kas1 microscopy Ventral root axon morphology. Nervous system microscopy. inbred   (6) m 20-34wks 2009
Kiernan1 study archive Ear microscopy (ampullae) and eye slit lamp study. QTL population f 2007
Kim1 study archive Glucose, insulin, body and fat pad weights. QTL population m 20-26wks 2001
Klaassen1 histopathology
with cadmium 		Cadmium-induced toxicity to liver, testis, trigeminal ganglia. inbred   (8) m 8wks 2001
Korstanje1 urinalysis Microalbumin, creatinine, ratio. Aging study, 6mo, 12mo, and 20mo. inbred   (30) both 52, 78, 104 wks 2008
Korstanje2 histopathology Kidney pathology. Aging study, 6mo, 12mo, 20mo. inbred   (29) m 52, 78, 104 wks 2013
Korstanje3 study archive
with high-fat diet 		Cholesterol and phospholipid transfer, baseline vs. high-fat diet. QTL population both 8-24wks 2004
Kumar4 gait analysis Angular velocity, Stride speed, Step length, Step width, and other gait metrics. inbred w/CC8   (62) both 10-20 wks 2021
Lake1 complete blood count Hematology. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 metabolic panel Glucose, bilirubin, aspartate transaminase (plasma). 4h fast. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 lipid profile Cholesterol, HDL, triglycerides, fatty acids. 4h fast, plasma. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 ECG Heart rate and wave intervals. Conscious. B6.A consomic w/par   (23) both 7-11wks 2005
Lake1 tail cuff Heart rate and blood pressure. Conscious mice. B6.A consomic w/par   (23) both 7-11wks 2005
Lake2 observation (SHIRPA) Behavior, and neurosensory responses (SHIRPA protocol). B6.A consomic w/par   (23) both 8wks 2005
Lake3 grip strength 3 trials. B6.A consomic w/par   (23) both 8-9wks 2005
Lazear1 organ weights Testis weight. CC   (12) m 13-21wks 2018
Lazear1 sperm count Sperm count. Computer assisted sperm analysis. CC   (12) m 13-21wks 2018
Lazear1 microscopy Male reproductive sperm motility. Computer assisted sperm analysis. CC   (12) m 13-21wks 2018
Lazear1 colony observation Litter size assessment. CC   (12) m 13-21wks 2018
Leiter2 study archive Type 1 diabetes development study. QTL population f 14-40wks 2009
Lesage1 immune cell quantification Immunological cell variation. CC w/par   (76) both 5-8wks 2018
Lesage2 immune cell quantification total number of splenocytes, number of B cells in spleen, and percentage of splenocytes that are B cells CC w/par   (76) both 5-8wks 2024
Levy1 computed tomography Bone microarchitecture, morphology (femur). CC pre   (31) both 8-14wks 2015
Li1 study archive
with western diet 		Lipids, atherosclerosis lesion histopathology. High-fat, western-style diet. QTL population f 12wks 2008
Lionikas1 microscopy
with exercise 		Muscle fibers. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 muscle weights
with exercise 		Various muscles. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 organ weights
with exercise 		Heart weight. Cardiac ventricle weight. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lionikas1 bone dimensions
with exercise 		Femur length. Exercised (swim endurance training regimen) vs. control at weekly intervals for 5wks. inbred   (6) m 11-14wks 2012
Lyons1 study archive
with high-fat diet 		Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population m 16-18wks 2003
Lyons2 study archive
with high-fat diet 		Lipids (plasma), bile, liver weight, gallbladder and gallstone histopathology. QTL population m 16-18wks 2003
Lyons3 study archive
with high-fat diet 		Lipids, gallbladder and gallstone histopathology after high-fat diet. QTL population m 14-20wks 2004
Lyons4 study archive
with high-fat diet 		Gallstone susceptibility. QTL population both 24-26wks 2005
Maeda1 study archive Atherosclerosis lesion histopathology, lesion sizes. QTL population both 18-20wks 2017
Mahler1 study archive Colitis susceptibility. Colon histopathology, spleen weight. QTL population both 6wks 2002
Marchuk1 histopathology Cerebral infarct volume, stroke susceptibility. Surgical occlusion of distal medial cerebral artery (MCA) to induce ischemia. inbred   (16) both 11-13wks 2009
Mathes1 MRI
with exercise 		Body composition (percent fat). Baseline vs. after exercise (access to running wheel). CC pre w/par   (184) m 10-12wks 2011
Mathes1 monitoring system
with exercise 		Respiratory exchange ratio. Baseline (before access to running wheel). CC pre w/par   (184) m 10-12wks 2011
Maurer1 organ weights
with atenolol, isoproterenol 		Heart, atria, ventricle weights. Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
Maurer1 tail cuff
with atenolol, isoproterenol 		Heart rate and blood pressure. Conscious mice. Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
Maurer1 ECG
with atenolol, isoproterenol 		Heart rate and wave amplitudes and intervals. Unconscious. Isoproterenol or atenolol vs. control. inbred   (23) m 10-12wks 2009
McMullan1 MRI Body composition (fat and lean mass and percent). CC   (50) f 17-72wks 2017
McMullan3 MRI Body composition (fat and lean mass) before, during, and after several weeks of exercise. CC   (43) f 20-88wks 2017
McMullan4 MRI
with exercise 		Body composition (fat and lean mass) before and after 2 weeks of exercise wheel availability. CC   (13) f 32-40wks 2018
McMullan6 MRI
with exercise 		Body composition (fat and lean mass) before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. CC   (4) both 8-10wks 2018
McMullan7 monitoring system
with exercise 		Locomotor activity, respiratory activity, body heat production, during 4 weeks of treadmill-based exercise training. 3 intensity cohorts. CC   (4) both 8-10wks 2018
Mills1 apoptosis assessment Aging study, 6mo, 12mo, 20mo. inbred   (30) both 26, 52, 87 wks 2008
Mills1 chromosome instability assessment Chromosome instability. Aging study, 6mo, 12mo, 20mo. inbred   (30) both 26, 52, 87 wks 2008
Molenhuis1 organ weights Brain weight. CC   (52) m 7-20wks 2018
Mooney1 protein activity assessment Acetylcholinesterase activity of cerebellum and dorsal and ventral hippocampus inbred   (20) m 8-12wks 2021
Mrug1 study archive Kidney morphology. QTL population both 1-2wks 2005
Nadeau2 metabolic panel
with high-fat high-sucrose diet 		Glucose, insulin, insulin resistance after 16wks of high-fat high-sucrose diet. 16h fast. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau2 lipid profile
with high-fat high-sucrose diet 		Cholesterol, triglycerides. 16h fast, plasma. Hepatic triglycerides. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau2 organ weights
with high-fat high-sucrose diet 		Liver weight after 16wks of high-fat high-sucrose diet. 16h fast. B6.A consomic w/par   (24) m 5, 21 wks 2015
Nadeau3 hormone quantification
with high-fat high-sucrose diet 		Insulin and insulin resistance after 16 wks of high-fat high-sucrose diet. Overnight fast. inbred   (2) m 21 wks 2016
Nadeau3 lipid profile
with high-fat high-sucrose diet 		Cholesterol and triglycerides. Overnight fast, plasma. Hepatic triglycerides. inbred   (2) m 21 wks 2016
Nadeau3 organ weights
with high-fat high-sucrose diet 		Liver weight after 16 wks of high-fat high-sucrose diet. Overnight fast. inbred   (2) m 21 wks 2016
Naggert1 DXA
with high-fat diet 		Body mass, fat mass, lean mass, bone mineral density and content after 8wks on high-fat diet. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 metabolic panel
with high-fat diet 		Glucose (plasma). Baseline vs. high-fat diet (17wks). 4h fast. inbred w/CC7   (43) both 5, 21 wks 2003
Naggert1 hormone quantification
with high-fat diet 		Insulin and leptin after 18wks on high-fat diet. Multiple readings per animal were averaged. inbred w/CC7   (43) both 5, 21 wks 2003
Nelson1 NMR
with restricted diet 		Body mass, fat mass, lean mass. Restricted diet vs. ad libitum diet. ILSXISS   (44) both max lifespan 2010
Neuner1 biomarker quantification Temporal cortex amyloid level, age 6 and 14 mo. F1 AD-BXD   (55) both 7-65wks 2019
Neuner1 grip strength Grip strength across 3 trials, age 6 mo and 14 mo. F1 AD-BXD   (55) both 7-65wks 2019
Nishihara1 study archive Blood pressure (tail cuff). QTL population m 10wks 2007
Noll1 immunoglobulin quantification IgM, IgG1, IgG2a + IgG2c, IgG2b, IgG3, total IgG CC RIX   (46) f 8-12 wks of age 2020
Odet1 organ weights Male reproductive organ weights. Testes, seminal vesicles, epididymis, vas deferens. inbred   (8) m 10-66wks 2015
Odet1 histopathology Male reproductive histopathology. Percent normal vs. abnormal sperm, seminiferous tubules. inbred   (8) m 10-66wks 2015
Odet1 sperm count Sperm count. Hemocytometer. inbred   (8) m 10-66wks 2015
Odet1 metabolic panel Male reproductive sperm lactate production. inbred   (8) m 10-66wks 2015
Odet2 microscopy Male reproductive sperm motility. inbred w/CC8   (8) m 10-66wks 2015
Paigen1 lipid profile
with high-fat diet 		Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 metabolic panel
with high-fat diet 		Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast. inbred   (44) both 15-19wks 2000
Paigen1 histopathology
with high-fat diet 		Gallstone, gallbladder, and atherosclerosis lesion histopathology after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 organ dimensions
with high-fat diet 		Gallbladder volume after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen1 organ weights
with high-fat diet 		Liver weight after 8wks on high-fat diet. inbred   (44) both 15-19wks 2000
Paigen2 histopathology
with high-fat diet 		Aortic lesion size histopathology. Baseline vs. high-fat diet (17wks). inbred w/CC7   (43) both 7-9wks, 24-27wks 2002
Paigen2 lipid profile
with high-fat diet 		Cholesterol, HDL, non-HDL, triglycerides. Baseline vs. high-fat diet (17wks). 4h fast, plasma. inbred w/CC7   (43) both 7-9wks, 24-27wks 2002
Paigen3 lipid profile
with high-fat diet 		Cholesterol, HDL, non-HDL. 4h fast, plasma. Hepatic lipids. 8wks on high-fat diet. obesity mutants   (8) both 15-19wks 2000
Paigen3 metabolic panel
with high-fat diet 		Alanine transaminase, bile salts (plasma) after 8wks on high-fat diet. 4h fast. obesity mutants   (8) both 15-19wks 2000
Paigen3 histopathology
with high-fat diet 		Gallstone, gallbladder, and atherosclerosis lesion histopathology after 8wks on high-fat diet obesity mutants   (8) both 15-19wks 2000
Paigen3 organ dimensions
with high-fat diet 		Gallbladder volume after 8wks on high-fat diet obesity mutants   (8) both 15-19wks 2000
Paigen3 organ weights
with high-fat diet 		Liver weight after 8wks on high-fat diet. obesity mutants   (8) both 15-19wks 2000
Paigen4 lipid profile Cholesterol, HDL, non-HDL, triglycerides. 4h fast, plasma. inbred w/CC7   (43) both 10wks 2002
Palmer3 acoustic startle test Acoustic startle response, prepulse inhibition. F1 Tcf7l2   (30) both 7-14wks 2017
Palmer3 metabolic panel Glucose (blood). Before and after 16h fast. F1 Tcf7l2   (30) both 7-14wks 2017
Palmer4 acoustic startle test
with methamphetamine 		Acoustic startle response. F1 Cacna1c   (30) both 7-14wks 2017
Palmer5 acoustic startle test Acoustic startle response, prepulse inhibition. F1 Tcf7l2   (30) both 7-14wks 2017
Palmer5 metabolic panel Glucose (blood). Before and after 16h fast. F1 Tcf7l2   (30) both 7-14wks 2017
Palmer6 acoustic startle test
with methamphetamine 		Acoustic startle response. F1 Cacna1c   (30) both 7-14wks 2017
Parker1 assisted reproduction Number of oocytes and number of fertilized oocytes. inbred   (6) f 3-6wks 2011
Payseur2 study archive Hybrid male sterility. Morphology, sperm count, histopathology. QTL population m 10-11wks 2018
Peters1 complete blood count Hematology. inbred w/CC7   (43) both 10wks 2001
Peters1 coagulation test Fibrinogen. inbred w/CC7   (43) both 10wks 2001
Peters2 complete blood count Hematology. AXB BXA   (28) both 11wks 2004
Peters4 complete blood count Hematology. Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (30) both 26, 52, 78, 104 wks 2007
Peters5 study archive Complete blood count measures on fetuses, newborns. QTL population both fetus, newborn 2004
Petkova1 immune cell quantification Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (32) both 26, 52, 78, 104 wks 2007
Petryshen1 acoustic startle test Acoustic startle response, prepulse inhibition. B6.A consomic   (22) m 7-9wks 2009
Pitman1 study archive
with high-fat diet 		Cholesterol (plasma) after high-fat diet (several timepoints). QTL population f 6-26wks 2002
Pletcher1 hormone quantification Corticosterone (serum). inbred   (32) m 7-9wks 2007
Poon1 histopathology Cell proliferation in the rostral migratory stream. BrdU+ cells. inbred   (9) both 13-78wks 2013
Powell1 in vitro assay
with Neisseria musculi 		Bacterial load after inoculation with Neisseria musculi. Oral cavity. inbred w/CC8   (8) both 8-16wks 2018
Puk1 organ dimensions Eye morphology. inbred   (4) both 13wks 2006
Reed1 fat pad weights Epididymal, retroperitoneal. inbred   (28) m 8, 12 wks 2009
Reed1 organ weights Heart, kidney weights. inbred   (28) m 8, 12 wks 2009
Reed2 organ weights Brain, heart, kidney, liver, pancreas, spleen weights. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Reed2 fat pad weights Comprehensive, several anatomical sites. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Reed2 DXA Body mass, fat mass, lean mass, bone mineral density and content, bone area. High-fat diet vs. control. Two age cohorts. B6.129 and 129.B6 consomic w/par   (9) both 26wks 2015
Reifsnyder1 study archive Body weight (several ages), fat mass, body mass index, fat pad weights. QTL population m 4-24wks 2000
Rhodes1 microscopy
with exercise 		Examination of hippocampus dentate gyrus. Exercise wheel group vs. control group. inbred   (12) both 8-15wks 2010
Rice1 proteomic profiling Hair proteomics analysis. Spectral counts for 46 specific proteins. inbred   (11) both 10-19wks 2012
Richards-Smith1 study archive
with macronutrient diet option 		Caloric intake, glucose, body and fat pad weights. Macronutrient diet option. QTL population m 8-13wks 2002
Richfield1 neurotransmitter quantification Neurotransmitters. Molecular measures. inbred   (15) m 7-9wks 2003
RIKEN-EAD1 metabolic panel Clinical blood chemistry (plasma). 4h fast. inbred RBRC   (56) both 8, 12 wks 2008
RIKEN-EAD1 complete blood count Hematology. inbred RBRC   (56) both 8, 12 wks 2008
RIKEN-EAD1 lipid profile Cholesterol, HDL, triglycerides. 4h fast, plasma. inbred RBRC   (56) both 8, 12 wks 2008
RIKEN-EAD1 body size and weight Body weight, body length, tail length. inbred RBRC   (56) both 8, 12 wks 2008
RIKEN-EAD2 metabolic panel Clinical blood chemistry (plasma). 4h fast. wild-derived RBRC   (33) both 8, 12 wks 2008
RIKEN-EAD2 complete blood count Hematology. wild-derived RBRC   (33) both 8, 12 wks 2008
RIKEN-EAD2 lipid profile Cholesterol, HDL, triglycerides. 4h fast, plasma. wild-derived RBRC   (33) both 8, 12 wks 2008
RIKEN-EAD2 body size and weight Body weight, body length, tail length. wild-derived RBRC   (33) both 8, 12 wks 2008
Rodriguez1 study archive Spleen, liver murine cytomegalovirus study. QTL population both 8-12wks 2009
Rosen1 histopathology Midsagittal area of corpus callosum. BXD w/par   (78) both various 2012
Rusyn2 metabolic panel
with trichloroethylene 		Blood urea nitrogen, alanine transaminase, aspartate transaminase (serum). Baseline and trichloroethylene-exposed (several timepoints). No fast. inbred   (17) m 7wks 2010
Rusyn2 drug and metabolite quantification
with trichloroethylene 		Trichloroethylene metabolites in serum, 2h, 4h, 24h after trichoroethylene exposure. inbred   (17) m 7wks 2010
Rusyn5 metabolic panel
with high-fat diet and ethanol 		Alanine transaminase (serum) after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 alcohol quantification
with high-fat diet and ethanol 		Alcohol concentration in blood and urine after 4 wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 organ weights
with high-fat diet and ethanol 		Liver weight after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 histopathology
with high-fat diet and ethanol 		Liver histopathology, injury after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 metabolite quantification
with high-fat diet and ethanol 		Homocysteine concentration after 4wk regimen of ethanol vs. control, both groups on high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 lipid profile
with high-fat diet and ethanol 		Hepatic triglycerides after 4wk regimen of ethanol and high-fat diet. 24h fast. inbred   (14) m 8-14wks 2011
Rusyn5 RNA expression profiling
with high-fat diet and ethanol 		Liver gene expression after 4wk regimen of ethanol and high-fat diet. 24h fast. mRNA abundance relative to the control (high-fat only) group. inbred   (14) m 8-14wks 2011
Rusyn6 organ weights
with trichloroethylene 		Liver, kidney weights. Trichloroethylene-exposed vs. control. inbred   (7) m 6-7wks 2014
Rusyn6 metabolic panel
with trichloroethylene 		Blood urea nitrogen (serum). Trichloroethylene-exposed vs. control. inbred   (7) m 6-7wks 2014
Rusyn6 drug and metabolite quantification
with trichloroethylene 		Trichloroethylene metabolite in blood, liver, kidney after trichloroethylene exposure. inbred   (7) m 6-7wks 2014
Rusyn6 RNA expression profiling
with trichloroethylene 		Trichloroethylene effect on mRNA gene expression in liver and kidney, relative to controls. inbred   (7) m 6-7wks 2014
Rusyn6 histopathology
with trichloroethylene 		Kidney histopathology evaluation after trichloroethylene exposure, relative to controls. inbred   (7) m 6-7wks 2014
Sandell1 health assessment Post-injury wound healing. Ear cartilage and articular cartilage. LGXSM w/par   (15) both 6-7wks 2012
Sandell1 histopathology Post-injury wound healing. Articular cartilage at 12wks and 16wks post-injury. LGXSM w/par   (15) both 6-7wks 2012
Schalkwyk2 RNA expression profiling Hippocampal microRNA expression. Normalized data. BXD w/par   (26) m 15-16wks 2012
Schauwecker1 health assessment
with pilocarpine 		Study of pilocarpine effect on epilepticus seizures. inbred   (11) m 8-10wks 2012
Schoenrock1 hormone quantification
with various diets 		Serum corticosterone at baseline and 10 mins after stress. Comparison of 4 diets. CC RIX   (18) f 8-9 wks 2018
Schonfeld1 glucose tolerance 0 to 120 min after 10% glucose i.p. 5h fast. inbred   (11) both 8-10wks 2005
Schonfeld1 insulin tolerance 0 to 120 min after insulin i.p. 5h fast. inbred   (11) both 8-10wks 2005
Schonfeld1 lipid profile Cholesterol, triglycerides, free fatty acids, phospholipids. 5h fast, plasma. Hepatic triglycerides. inbred   (11) both 8-10wks 2005
Schonfeld1 metabolic panel Glucose, beta-hydroxybutyrate (plasma). No fast. inbred   (11) both 8-10wks 2005
Schonfeld1 organ weights Liver weight. inbred   (11) both 8-10wks 2005
Schonfeld1 DXA Fat mass. inbred   (11) both 8-10wks 2005
Schonfeld1 hormone quantification Insulin level, 30 min post-injection in glucose tolerance test. 10% glucose. 5h fast. inbred   (11) both 8-10wks 2005
Schoonjans1 glucose tolerance
with high-fat diet 		Plasma glucose levels at 0, 30, 60 min post oral gavage of Ensure Plus, overday fast. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 biomarker quantification
with high-fat diet 		Bile acid levels in plasma, feces, and liver. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 organ weights
with high-fat diet 		Liver, spleen, kidney, fat pads, muscles, cecum. BXD w/par   (36) m 8-29 wks 2022
Schoonjans1 organ dimensions
with high-fat diet 		Small intestine length. BXD w/par   (36) m 8-29 wks 2022
Schughart4 complete blood count
with influenza A (H3N2) virus 		White blood cell count and differentials. Influenza A (H3N2) virus vs. controls. inbred w/CC8   (8) f 8-12wks 2016
Schughart4 in vitro assay
with influenza A (H3N2) virus 		Viral load in lungs after infection with influenza A (H3N2) virus. inbred w/CC8   (8) f 8-12wks 2016
Schulz1 ventilator Lung, respiratory function. inbred   (7) both 9-18wks 2000
Schwartz2 bronchoalveolar lavage assessment
with ovalbumin 		Lung inflammatory changes. Ovalbumin vs. control. inbred   (8) m 6-8wks 2001
Seburn1 monitoring system Locomotor activity and energy metabolism. 24h test. inbred   (16) both 7-9wks 2001
Seburn2 grip strength Peak tension. 3 trials. Aging study, 6mo, 12mo, 18mo, 24mo. inbred   (32) both 26, 52, 78, 104 wks 2008
Seburn2 gait analysis Aging study, 6mo, 18mo. inbred   (32) both 26, 52, 78, 104 wks 2008
Sheehan1 study archive Urinalysis. Creatinine, microalbumin, body weight. QTL population m 10wks 2007
Shockley1 lipid profile
with high-fat diet 		Cholesterol, HDL, triglycerides, fatty acids. High-fat diet (4wks) vs. control. 5h fast, serum. inbred   (10) both 10-13wks 2008
Shockley1 metabolic panel
with high-fat diet 		Clinical blood chemistry measures (serum). High-fat diet (4wks) vs. control. inbred   (10) both 10-13wks 2008
Shorter2 organ weights
with various diets 		Heart weight, raw, adjusted to body weight, adjusted to femur length. Diets vs controls. DO population both 12-15wks, 24-25wks 2018
Shorter2 bone dimensions
with various diets 		Femur length. Diets vs controls. DO population both 12-15wks, 24-25wks 2018
Shorter3 colony observation Litter size assessment. CC diallel w/par   (62) f 3wks 2018
Shorter4 organ weights Male reproductive organ weights. Testes, seminal vesicles, epididymis + vas deferens. CC   (12) m 15-33wks 2020
Shorter4 sperm count Sperm count. Hemocytometer. CC   (12) m 15-33wks 2020
Shorter4 microscopy Sperm motility CC   (12) m 15-33wks 2020
Shorter4 histopathology Male reproductive histopathology. Percent normal, abnormal sperm. CC   (12) m 15-33wks 2020
Shorter5 organ weights Male reproductive organ weights. Testes, seminal vesicles, epididymis + vas deferens. CC RIX   (28) m 7-44wks 2020
Shorter5 sperm count Sperm count. Hemocytometer. CC RIX   (28) m 7-44wks 2020
Shorter5 microscopy Sperm motility CC RIX   (28) m 7-44wks 2020
Shorter5 histopathology Male reproductive histopathology. Percent normal, abnormal sperm. CC RIX   (28) m 7-44wks 2020
Shorter6 microscopy Sperm motility. CC   (12) m 15-33wks 2020
Shorter7 microscopy Sperm motility. CC RIX   (28) m 7-44wks 2020
Shorter8 organ weights Male reproductive organ weights. Testes, seminal vesicles, epididymis + vas deferens. DO population m 12-15wks 2020
Shorter8 sperm count Sperm count. Hemocytometer. DO population m 12-15wks 2020
Shorter8 microscopy Sperm motility DO population m 12-15wks 2020
Shorter8 histopathology Male reproductive histopathology. Percent normal, abnormal sperm. DO population m 12-15wks 2020
Solberg1 study archive Open field test, forced swim test, defensive burying task. QTL population both 11-17wks 2004
Spijker1 acoustic startle test Acoustic startle response, prepulse inhibition. BXD w/par   (45) m 8wks 2011
Stylianou1 study archive
with high-fat diet 		Body size, weight, fat pad weights after high-fat diet. QTL population both 24wks 2006
Stylianou2 study archive Lipids. Cholesterol, triglycerides, body weight. QTL population both 8-10wks 2006
Su2 study archive
with high-fat diet 		Lipids (plasma). Cholesterol, triglycerides, aortic lesions, body mass index. QTL population f 14wks 2009
Sugiyama1 tail cuff Heart rate and blood pressure. Conscious mice. inbred   (25) m 10wks 2007
Sugiyama2 study archive
with sodium chloride 		Blood pressure (tail cuff) after sodium chloride intake. QTL population m 10wks 2001
Sugiyama3 study archive Blood pressure (tail cuff), heart weight, body weight. QTL population m 10wks 2002
Sundberg2 study archive Alopecia areata autoimmune disease susceptibility. QTL population both 52wks 2003
Sunde1 RNA expression profiling
with selenium 		Selenium regulation of selenoprotein enzyme activity and transcripts. inbred w/CC8   (8) m 3-14wks 2018
Svenson1 tail cuff Heart rate and blood pressure. Conscious mice. inbred   (14) both 9wks 2004
Svenson3 complete blood count Hematology. B6.PWD consomic w/par   (28) both 9wks 2006
Svenson3 coagulation test Fibrinogen, anti-thrombin III, factor VIII B6.PWD consomic w/par   (28) both 9wks 2006
Svenson3 metabolic panel Glucose, bilirubin, blood urea nitrogen, aspartate transaminase (plasma). 4h fast. B6.PWD consomic w/par   (28) both 9wks 2006
Svenson3 lipid profile Cholesterol, HDL, triglycerides, free fatty acids. 4h fast, plasma. B6.PWD consomic w/par   (28) both 9wks 2006
Svenson4 DXA Body mass, fat mass, lean mass, bone mineral density and content. B6.PWD consomic w/par   (28) both 16wks 2006
Svenson7 body weight
with high-fat high-sucrose diet 		Body weight from 3-30 wks of age. Principal components. DO population both 3-30 wks 2020
Svenson7 metabolic panel
with high-fat high-sucrose diet 		Clinical chemistry at 8 and 19 wks of age. 4h fast. Clinical chemistry at 17 wks of age. No fast. DO population both 3-30 wks 2020
Svenson7 lipid profile
with high-fat high-sucrose diet 		Cholesterol, fatty acids, triglyceride at 8 and 19 wks of age. 4h fast. DO population both 3-30 wks 2020
Svenson7 complete blood count
with high-fat high-sucrose diet 		Hematology at 10 and 22 wks of age. DO population both 3-30 wks 2020
Svenson7 urinalysis
with high-fat high-sucrose diet 		Glucose, creatinine, microalbumin, albumin-creatinine ratio at 11 and 20 wks of age. DO population both 3-30 wks 2020
Svenson7 DXA
with high-fat high-sucrose diet 		Body mass, lean mass, fat mass, bone mineral density at 12 and 21 wks of age. DO population both 3-30 wks 2020
Svenson7 ECG
with high-fat high-sucrose diet 		Heart rate and wave intervals at 13 wks. Conscious. DO population both 3-30 wks 2020
Svenson7 MRI
with high-fat high-sucrose diet 		Lean and fat tissue mass, water mass at 16 wks of age. DO population both 3-30 wks 2020
Svenson7 glucose tolerance
with high-fat high-sucrose diet 		0-180 min after 20% glucose i.p. at 23-24 wks of age. 15h fast. DO population both 3-30 wks 2020
Taft1 assisted reproduction Performance following assisted reproductive technologies. inbred   (10) f various 2006
Threadgill1 metabolic panel
with acetaminophen 		Blood urea nitrogen, alanine transaminase, aspartate transaminase (serum), liver enzyme homeostasis. Acetaminophen (several doses) vs. control, several timepoints post-Rx. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 histopathology
with acetaminophen 		Liver histopathology, necrosis after acetaminophen vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 metabolite quantification
with acetaminophen 		Liver protein homeostasis. Acetaminophen vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 biomarker quantification
with acetaminophen 		Liver cytochrome isoforms. Acetaminophen vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill1 organ weights
with acetaminophen 		Liver weight after acetaminophen (several doses) vs. control. 18h fast. inbred w/CC7   (37) m 8-17wks 2005
Threadgill2 metabolic panel
with acetaminophen 		Alanine transaminase (serum). Acetaminophen (several doses) vs. control. inbred   (5) m 6-8wks 2005
Threadgill2 metabolite quantification
with acetaminophen 		Glutathione. inbred   (5) m 6-8wks 2005
Threadgill2 drug and metabolite quantification
with acetaminophen 		Acetaminophen metabolite concentrations (serum) and liver protein homeostasis. Baseline vs. acetaminophen (several doses, several timepoints). inbred   (5) m 6-8wks 2005
Threadgill2 histopathology
with acetaminophen 		Liver histopathology, necrosis, injury after acetaminophen vs. control. 18h fast. inbred   (5) m 6-8wks 2005
Tomasini1 biomarker quantification Fibronectin. inbred   (25) both 9wks 2007
Tordoff1 bottle choice test Various salt solutions (several concentrations) vs. water. inbred   (28) m 9wks 2001
Tordoff3 bottle choice test Various salt solutions (several concentrations) vs. water. inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 DXA Body mass, fat mass, lean mass, bone mineral density and content. inbred w/CC7   (40) both 9-15wks 2002
Tordoff3 metabolic panel Ionized and total blood calcium, blood pH. inbred w/CC7   (40) both 9-15wks 2002
Trullas1 hormone quantification Corticosterone levels (plasma). Baseline vs. after stress (30 min in restraining cage). inbred   (16) m 6-8wks 1993
Tsaih1 study archive Brain weight, body weight. QTL population both 2005
Vinyard1 bone dimensions Craniofacial bone dimensions. inbred   (21) both 6-8wks 2009
Vulpe1 mineral quantification Liver mineral levels. Iron, copper, zinc. Iron homeostasis. inbred   (18) both 8wks 2010
Vulpe1 transferrin quantification Diferric transferrin (plasma). inbred   (18) both 8wks 2010
Wahlsten1 organ weights Brain weight. inbred   (21) both 9, 12 wks 2003
Wahlsten1 histopathology Corpus callosum, hippocampus, anterior commisure. inbred   (21) both 9, 12 wks 2003
Wang1 study archive
with high-fat diet 		Lipids (plasma). Cholesterol, inducibility, triglycerides, atherosclerosis lesions. QTL population f 10-23wks 2003
Wergedal1 study archive Bone mineral density, thickness, strength. QTL population f 10wks 2006
Williams1 immune cell quantification CD4 T cells, various populations. inbred   (5) f 8wks 2012
Willott1 acoustic startle test Acoustic startle response, prepulse inhibition. inbred w/CC7   (40) both 5-6wks 2002
Wiltshire2 drug and metabolite quantification
with fluoxetine 		Fluoxetine and norfluoxetine concentration (serum) after fluoxetine. inbred   (30) m 9-11wks 2011
Wiltshire3 biomarker quantification
with fluoxetine 		Brain tissue survey of 30 biochemical analytes. Fluoxetine-treated vs. control. 21d. inbred   (30) m 10-11wks 2011
Wiltshire4 immune cell quantification
with BEZ235, doxorubicin, idarubicin, selumetinib 		In vitro study of 4 cancer chemotherapies (BEZ235, doxorubicin, idarubicin, selumetinib) vs. control. Effect on immune cells. Normalized data. inbred w/CC7   (36) m 10wks 2015
Wittenburg1 study archive
with high-fat diet 		Liver weight, gallbladder and gallstone histopathology. QTL population both 18-20wks 2002
Wittenburg2 study archive
with high-fat diet 		Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population both 6-16wks 2003
Wittenburg3 study archive
with high-fat diet 		Lipids (plasma), liver weight, gallbladder and gallstone histopathology. QTL population both 2005
Xenakis1 drug and metabolite quantification Plasma haloperidol concentration. CC RIX   (73) both 7-13wks 2020
Xenakis2 MRI
with arsenic 		Fat and lean tissue mass at baseline, and 12 and 24 wks after iAs exposure DO population m 4-34 wks 2022
Xenakis2 urinalysis
with arsenic 		Urine volume at baseline, and 12 and 24 wks after iAs exposure DO population m 4-34 wks 2022
Xenakis2 metabolic panel
with arsenic 		Blood glucose following 6 h fast, and after intraperitoneal glucose injection; at baseline and after iAs exposure DO population m 4-34 wks 2022
Xenakis2 hormone quantification
with arsenic 		Blood insulin following 6 h fast, and after intraperitoneal glucose injection; at baseline and after iAs exposure DO population m 4-34 wks 2022
Xenakis2 metabolite quantification
with arsenic 		iAs quantification in urine and liver, at 24 and 26 wks after iAs exposure. IAs speciation evaluated specifically monomethyl-arsenic acid (MMA) and dimethyl-arsenic acid (DMA) DO population m 4-34 wks 2022
Xing1 ECG Heart rate and wave intervals. Conscious. Aging study, 6mo, 12mo, 20mo. inbred   (29) both 26, 52, 87 wks 2008
Xing2 gait analysis Aging study, 6mo, 12mo, 18mo. inbred   (31) both 26, 52, 78 wks 2010
Yi1 study archive Body weight (several timepoints) and liver weight. QTL population both 2-12wks 2007
Yuan1 hormone quantification Insulin-like growth factor 1 (serum). Aging study, 6mo, 12mo, and 18mo. inbred   (33) both 26, 52, 78 wks 2007
Yuan3 metabolic panel Clinical blood chemistry. Aging study, 6mo, 12mo, 18mo. inbred   (32) both 26, 52, 78 wks 2008
Yuan3 lipid profile Cholesterol (HDL). Aging study, 6mo, 12mo, 18mo. 4h fast, plasma. inbred   (32) both 26, 52, 78 wks 2008
Yuan4 colony observation Observed age at vaginal opening (patency). Aging study. inbred   (33) f 2-9wks 2009
Yuan5 study archive Plasma levels of P-selectin and soluble vascular cell adhesion molecule-1. QTL population f 18wks 2008
Zaytseva1 glycosylation profile IgG glycan peaks, relative abundance CC   (111) both 4-140wks 2018
Zaytseva2 glycosylation profile IgG subclasses, relative abundance CC   (95) both 20-117wks 2018
Zhang1 study archive
with western diet 		Atherosclerosis and glucose homeostasis. Lesions, lipids, glucose, insulin. High-fat, western-style diet. QTL population f <6-18wks 2012
Zheng1 tympanometry Middle ear function. inbred   (61) both 15-51d 2008
Zimmermann1 monitoring system Voluntary activity and energy expenditure. 2-day test, second day data analyzed during 12:12h light and dark periods. inbred   (30) both 7-15 wks 2020